Joint KDA-IAS Session at 2023 ICDM
Date: 21 October 2023
In this session, speakers will discuss many important topics of anti-diabetic treatment and cardiovascular diseases:
- Update of KDA guidelines focused on SGLT 2 inhibitor and GLP1 therapy
- SGLT2 inhibitor and CVOTs
- GLP 1-based therapy and its effect on CVDs
- Recent update of familial hypercholestrolemia treatment.